Nippon Chemiphar Competitors and Similar CompaniesClear all
Nippon Chemiphar's competitors and similar companies include Nobelpharma, Cosmo Pharmaceuticals, TRB Chemedica and PhaseBio Pharmaceuticals.
 Nippon Chemiphar Nippon Chemiphar is a pharmaceutical company that specializes in the development of generic drugs. |  Nobelpharma Nobelpharma (ノーベルファーマ) is a pharmaceutical company that is engaged in the research and development of medicines and medical devices. |  Cosmo Pharmaceuticals Cosmo Pharmaceuticals is a company that focuses on solutions in the areas of astroenterology and endoscopy. |  TRB Chemedica TRB Chemedica is a company specializing in the production of active pharmaceutical ingredients (APIs), pharmaceutical products, and medical devices. |  PhaseBio Pharmaceuticals PhaseBio Pharmaceuticals is a biopharmaceutical company committed to developing new and improved drugs, with an initial focus on endocrine and metabolic disorders and cardiovascular disease. | |
Founding Date | Founding Date 1950 | Founding Date 2003 | Founding Date 1997 | Founding Date 1980 | Founding Date 2002 |
Type | Type Public | Type Private | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations Chiyoda City, JP HQ Fukuoka, JP Osaka, JP Saitama, JP Sapporo, JP Sendai, JP | Locations Chuo City, JP HQ | Locations Dublin, IE HQ | Locations Genève, CH HQ Buenos Aires, AR Biedermannsdorf, AT Campinas, BR Archamps, FR Feldkirchen, DE Sai Ying Pun, HK see more | Locations Malvern, US HQ |
Employees | Employees 887 | Employees 269 | Employees 321 | Employees 900 | Employees 22 |
Valuation ($) | Valuation ($) 34.7 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) ¥32.6b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) €104.2m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $10.8m (FY, 2021) |
Cost of goods | Cost of goods ¥22.4b (FY, 2025) | Cost of goods N/A | Cost of goods €40.4m (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit ¥10.1b (FY, 2025) | Gross profit N/A | Gross profit €70.9m (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income ¥294m (FY, 2025) | Net income N/A | Net income (€3.5m) (FY, 2025) | Net income N/A | Net income ($131.1m) (FY, 2021) |
For sources of this data, please see the company profile
View Company Profiles
Nobelpharma
HQ
Chuo City, JP
Employees
269
Nobelpharma (ノーベルファーマ) is a pharmaceutical company that is engaged in the research and development of medicines and medical devices.
View companyCosmo Pharmaceuticals
HQ
Dublin, IE
Employees
321
Cosmo Pharmaceuticals is a company that focuses on solutions in the areas of astroenterology and endoscopy.
View companyTRB Chemedica
HQ
Genève, CH
Employees
900
TRB Chemedica is a company specializing in the production of active pharmaceutical ingredients (APIs), pharmaceutical products, and medical devices.
View companyPhaseBio Pharmaceuticals
HQ
Malvern, US
Employees
22
PhaseBio Pharmaceuticals is a biopharmaceutical company committed to developing new and improved drugs, with an initial focus on endocrine and metabolic disorders and cardiovascular disease.
View company